American Health Council Names Pamela Stanley, Ph.D. to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
American Health Council Names Pamela Stanley, Ph.D. to Education Board

NEW YORK, Dec. 22, 2016 (GLOBE NEWSWIRE) -- Dr. Pamela Stanley, Professor of Cell Biology at Albert Einstein College of Medicine and Horace W. Goldsmith Foundation Chair, has been selected to join the Education Board at the American Health Council. She will be sharing her knowledge and expertise in Glycobiology and Developmental Biology.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/Attachm...053e60e874

Dr. Stanley has been active in biomedical research for the past 39 years. She obtained her PhD in Virology and Biochemistry in 1972 from the University of Melbourne in Australia and did postdoctoral work at the University of Toronto supported by a MRC Fellowship.

Dr. Stanley has been Professor of Cell Biology at Albert Einstein College of Medicine for 27 years and Horace W. Goldsmith Foundation Chair for 9 years. Her day-to-day responsibilities include mentoring post-doctoral fellows and graduate students in investigations of roles for mammalian glycans in development, cancer, and Notch signaling. She also offers a graduate course in Glycobiology.

Albert Einstein College of Medicine is a premier, research-intensive medical school dedicated to innovative biomedical investigation and the development of ethical and compassionate physicians and scientists. Dr. Stanley takes great pride in being able to make a difference in the lives of post-graduate trainees at such a prestigious institution.

Dr. Stanley’s area of expertise is in diseases that stem from defects in the biosynthesis of glycans, often termed congenital disorders of glycosylation (CDG). Each disease is usually inherited and rare, but together the CDGs comprise mutations in more than 100 human genes. She has been supported by grants from the National Institutes of Health since 1980 and has also received grants from the American Cancer Society, the National Science Foundation and the Mizutani Foundation.

Dr. Stanley, whose interest in science began at the age of 14, attributes success throughout her career to having a keen interest in understanding and discussing experimental details, being flexible, working hard, persevering, and sharing information and reagents with others. She is proud of the extensive research produced by the members of her laboratory on isolating and identifying biochemical and genetic bases of Chinese hamster ovary (CHO) cell glycosylation mutants, in using these mutants, as well as developing mutant mice, to understand functions of of glycans in development and Notch signaling. Her current goals include determining roles for complex N-glycans in spermatogenesis, and for O-glycans in Notch signaling. She is on the Editorial Board of Glycobiology, Glycoconjugate Journal, F1000 Research Reports and Scientific Reports. She is a member of AAUWA, NYAS, ASBMB, ASCB, and SFG, and is a past President of the Society for Glycobiology (SFG).

Dr. Stanley’s awards and honors include: Dunlop Prize for First Place in Biochemistry (1966 and 1967); Australian Society for Microbiology Prize for Virology (1968); Commonwealth post-graduate award (1969-1972); Postdoctoral Fellowship from the Medical Research Council of Canada (1972-1975); American Cancer Society Faculty Awards (1978-1981 and 1981-1983); Irma T. Hirschl Faculty Award (1985-1990); election to Leo M. Davidoff Society for Excellence in Teaching (1987); MERIT Award from the National Cancer Institute, NIH (1991); Dorothy Baugh Harmon Lectureship, Oklahoma Med Res Foundation (1997); Mizutani Awards (2001, 2013); International Glycoconjugate Organization Award (2003); Karl Meyer Award, Society for Glycobiology (2003); Horace W. Goldsmith Foundation Chair (2007); LaDonne Shulman award for graduate teaching (2009); Goldstein Lecture, Dept. Biological Chemistry, U. Michigan, Ann Arbor (2010); Peter Gallagher memorial lecture, Griffith University, Australia (2012); Marshall Horwitz Faculty Prize for Research Excellence (2014); and WALS lecture, National Institutes of Health (2015).

Dr. Stanley can converse in French. In her free time, she enjoys playing tennis and piano, swimming, and reading.

For more information, please contact: Elizabeth Moore American Health Council Hauppauge, NY United States Phone: 1-212-390-0214 Email: media@americanhealthcouncil.org

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MERSCO’s Holiday Push Tests Backyard Play Demand in 2026

Updated Category News Views 61

A trampoline sale is not exactly a macroeconomic bellwether, but it does expose a useful little corner of holiday spending: parents buying big, awkward, discretionary stuff that has to earn its space in the yard. MERSCO is joining Amazon’s Black Friday and Cyber Monday window from November 19 through November 30, 2026, with discounts reaching 38% on selected products....

Continue Reading
Markley’s Lowell Campus Turns Data Land Into Arboretum

Updated Category News Views 106

Server halls rarely get credited with restoring a landscape, which is why Markley’s Lowell campus caught my eye. On November 18, 2026, the company said its Lowell data center campus had earned Level I arboretum accreditation from the ArbNet Arboretum Accreditation Program. ArbNet describes itself as the only international accreditation program specifically for arboreta,...

Continue Reading
America's Group Adds Swansea to Its UK Auction Map

Updated Category News Views 117

A Welsh Lane Joins a Larger Road Port Talbot just became a small but telling dot on America's Group's international map. The company has acquired Swansea Motor Vehicle Auction Limited, a long-standing South Wales wholesale and remarketing operation, and plans to run it under the G3 brand. This is not the sort of deal that makes markets levitate. It is the sort that tells...

Continue Reading
Volta M100 Puts Flexibility at Pad Printing's Center

Updated Category News Views 61

A tabletop printer rarely earns a second glance, but the Volta M100 is making a sensible argument: small manufacturers do not need another rigid box that becomes obsolete the minute a job changes. Boston Industrial Solutions has introduced the Volta M100 as a pad-printing machine built around adjustability, operator convenience, and software that can be upgraded as...

Continue Reading
Lummus-Versalis Deal Adds Nine Elastomer Technologies

Updated Category News Views 104

Nine elastomer technologies do not make a flashy headline, yet this is the sort of chemical-industry move that can matter long after the applause dies down. Lummus Technology and Versalis have expanded their partnership to cover nine elastomer technologies. That is the disclosed fact, and it is meaningful on its own. The release does not lay out contract value, duration,...

Continue Reading
Workday GO for Financials Targets the Messy Middle

Updated Category News Views 182

Spreadsheets rarely die gracefully; they get buried under approvals, reconciliations, and the frantic scavenger hunt before an audit. Workday is aiming straight at that unpleasant moment with Workday GO for Financials, announced November 18 at Workday Rising EMEA in Barcelona. The pitch is not terribly romantic, thank goodness. It is a simpler way for growing companies to...

Continue Reading
RazorMetrics' Fast 500 Run Merits a Harder Investor Look

Updated Category News Views 66

A 4,488% growth figure can make even a seasoned skeptic sit upright. RazorMetrics landed at No. 20 on Deloitte's 2026 Technology Fast 500 after ranking No. 12 in 2025, and it again took the top Texas slot. That is serious momentum for an Austin company working on one of healthcare's most stubborn expenses: prescription drugs. Still, this is healthcare cost containment,...

Continue Reading
Mantle's Japan Listing Puts $MNT Through a Real Test

Updated Category News Views 173

Japan's crypto gatekeepers just handed Mantle a key, not a crown. The November 18 listing of $MNT on GMO Coin is a meaningful operational win because getting onto a Japanese centralized exchange is not the usual loose-change exercise seen in friendlier jurisdictions. Mantle cleared a review process involving GMO Coin and the Japan Virtual and Crypto Assets Exchange...

Continue Reading
Anycubic Pushes Toward a Smoother 3D Printing Ecosystem

Updated Category News Views 125

Friction Is the Enemy in Consumer 3D Printing A printer that makes a beautiful object only after three failed attempts is not a consumer product; it is a weekend argument with plastic. That is the useful lens for Anycubic's Formnext 2026 showing in Frankfurt on November 18. The company is not merely rolling out FDM and resin machines at Booth F01 in Hall 12.0. It is...

Continue Reading
Three Deal Reviews Put Merger Terms Under Scrutiny

Updated Category News Views 140

Three proposed transactions just picked up the sort of legal glare boards hate seeing. A shareholder-rights firm, Halper Sadeh, said on November 18, 2026 that it is investigating whether the deals involving Greenland Energy, Rapid Micro Biosystems and Aytu BioPharma may involve federal securities-law violations or breaches of fiduciary duty. That is an allegation worth...

Continue Reading

Top 5 Most Recently Viewed Articles

Ford Motor Company Faces Legal Challenges: Key Insights

Updated Category News Views 119

Understanding the Legal Landscape for Ford Motor Company As investors navigate the intricate world of stock ownership, recent events surrounding Ford Motor Company have raised eyebrows. The company currently finds itself at the center of a class action lawsuit involving shareholders who acquired stock during a specific period. Class Action Overview and Important Dates...

Continue Reading
Transforming the Specialty Fats and Oils Industry for Success

Updated Category News Views 188

A Deep Dive into the Specialty Fats and Oils Market The landscape of the specialty fats and oils market is rapidly transforming, growing from its valuation of US$ 16.12 billion in the preceding year to a staggering US$ 31.69 billion by 2033, marking a robust CAGR of 7.8% during the next financial stretch. This growth signals a significant shift in industry dynamics and...

Continue Reading
C3.ai: Analyzing Current Trends in the Options Market

Updated Category News Views 241

Current Sentiment on C3.ai Recently, well-known investors—often referred to as whales—have taken a decidedly negative stance towards C3.ai. This growing skepticism stems from the history of options involving the company's stock. An analysis of C3.ai's (AI) trading patterns uncovered nine notable trades. Digging deeper into these transactions shows that only 22% of...

Continue Reading
CytomX Therapeutics Completes $100 Million Stock Offering

Updated Category News Views 315

CytomX Therapeutics Completes $100 Million Stock Offering CytomX Therapeutics, Inc. (NASDAQ: CTMX), based in South San Francisco, has just announced the pricing of an extensive stock offering. The company is set to offer 76,923,076 shares of its common stock at a price of $1.30 per share. This significant transaction aims to raise approximately $100 million and is being...

Continue Reading
Wall Street's Bullish Coverage Initiation Highlights for NKE and Others

Updated Category News Views 120

Wall Street Analysts Initiate Coverage on Key Stocks In a dynamic market landscape, top analysts have recently adjusted their ratings on several prominent companies. Their insights provide a glimpse into potential future performance for investors. Today, we spotlight these analyst ratings and what they mean for some notable stocks. NIKE, Inc. (NKE) Coverage by Needham...

Continue Reading